These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2098268

  • 1. Quantitative cytomorphology of megakaryocytes in chronic myeloproliferative disorders--analysis of planimetric and numeric characteristics by means of a knowledge based system.
    Nafe R, Kaloutsi V, Fritsch RS, Georgii A.
    Exp Pathol; 1990; 40(4):213-9. PubMed ID: 2098268
    [Abstract] [Full Text] [Related]

  • 2. Megakaryocytes in chronic myeloproliferative disorders: numerical density correlated between different entities.
    Kaloutsi V, Fritsch RS, Buhr T, Restrepo-Specht I, Widjaja W, Georgii A.
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(6):493-7. PubMed ID: 2058083
    [Abstract] [Full Text] [Related]

  • 3. [Morphometry of megakaryocytes for supporting the histologic diagnosis of chronic myeloproliferative diseases].
    Nafe R, Holgado de Colombo S, Choritz H, Georgii A.
    Pathologe; 1995 Jan; 16(1):34-40. PubMed ID: 7886012
    [Abstract] [Full Text] [Related]

  • 4. Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders.
    Nafe R, Georgii A, Kaloutsi V, Fritsch RS, Choritz H.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991 Jan; 61(2):111-6. PubMed ID: 1683718
    [Abstract] [Full Text] [Related]

  • 5. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I, Galatâr N.
    Morphol Embryol (Bucur); 1989 Jan; 35(2):117-27. PubMed ID: 2529429
    [Abstract] [Full Text] [Related]

  • 6. [Histopathology of Ph1-negative chronic myeloproliferative diseases].
    Georgii A, Choritz H, Büsche G, Kreft A, Buhr T.
    Pathologe; 1995 Jan; 16(1):62-9. PubMed ID: 7886016
    [Abstract] [Full Text] [Related]

  • 7. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.
    Thiele J, Funke S, Holgado S, Choritz H, Georgii A.
    Anal Quant Cytol; 1984 Sep; 6(3):155-67. PubMed ID: 6594964
    [Abstract] [Full Text] [Related]

  • 8. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
    Bartl R, Frisch B, Wilmanns W.
    Eur J Haematol; 1993 Jan; 50(1):41-52. PubMed ID: 8436214
    [Abstract] [Full Text] [Related]

  • 9. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R, Marzetta K, Miglioranza A, Redaelli S, Maino C, Maffiolini A, Gorini M.
    Recenti Prog Med; 2003 Jan; 94(7-8):314-20. PubMed ID: 12868237
    [Abstract] [Full Text] [Related]

  • 10. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A.
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [Abstract] [Full Text] [Related]

  • 11. The histopathology of chronic myeloproliferative diseases.
    Georgii A, Buesche G, Kreft A.
    Baillieres Clin Haematol; 1998 Dec; 11(4):721-49. PubMed ID: 10640214
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia.
    Michiels JJ.
    Neth J Med; 1997 Aug; 51(2):57-64. PubMed ID: 9286142
    [Abstract] [Full Text] [Related]

  • 13. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP, Sanchez SR, Ewton AA, Rice L, Perkins SL, Dunphy CH, Chang CC.
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [Abstract] [Full Text] [Related]

  • 14. Chronic myeloproliferative disorders (CMPD).
    Burkhardt R, Bartl R, Jäger K, Frisch B, Kettner G, Mahl G, Sund M.
    Pathol Res Pract; 1984 Nov; 179(2):131-86. PubMed ID: 6395125
    [Abstract] [Full Text] [Related]

  • 15. Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders.
    Lichtman MA.
    Leukemia; 2005 Jul; 19(7):1139-41. PubMed ID: 15902283
    [No Abstract] [Full Text] [Related]

  • 16. [Chronic myeloproliferative disorders. The new WHO classification].
    Thiele J, Kvasnicka HM.
    Pathologe; 2001 Nov; 22(6):429-43. PubMed ID: 11766643
    [Abstract] [Full Text] [Related]

  • 17. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N, Stacher E, Regitnig P, Zinke-Cerwenka W, Hojas S, Hubmann E, Porwit A, Bjorkholm M, Hoefler G, Beham-Schmid C.
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [Abstract] [Full Text] [Related]

  • 18. Abnormalities of megakaryocytes in myelitis and chronic myeloproliferative diseases.
    Thiele J, Holgado S, Choritz H, Georgii A.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1982 Sep; 41(1-2):67-81. PubMed ID: 6134385
    [Abstract] [Full Text] [Related]

  • 19. Objective, planimetry-based assessment of megakaryocyte histological pictures in Philadelphia-chromosome-negative chronic myeloproliferative disorders: a perspective for a valuable adjunct diagnostic tool.
    Rudzki Z, Kawa R, Okoñ K, Szczygieł E, Stachura J.
    Virchows Arch; 2006 Jan; 448(1):59-67. PubMed ID: 16220296
    [Abstract] [Full Text] [Related]

  • 20. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
    Michiels JJ, Thiele J.
    Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.